Viatris Inc is a global healthcare company that provides a wide range of products, including prescription brand drugs, generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) across various therapeutic areas. With a focus on both noncommunicable and infectious diseases, the company offers treatments in oncology, immunology, endocrinology, ophthalmology, and dermatology among others. Viatris distributes its products to retail and pharmacy establishments, wholesalers, insurers, and governments worldwide, ensuring access to quality medicines. Founded in 1961 and based in Canonsburg, Pennsylvania, Viatris is committed to supporting patient health through its extensive portfolio and services.
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash,…
Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla, Under Armour, Ventas, Viatris, Wayfair and Welltower.
Friday's top analyst upgrades and downgrades included Activision Blizzard, Altria, AppLovin, Bumble, Cano Health, Hanesbrands, Okta, Palo Alto Networks, Redfin, RingCentral, Rivian Automotive, Roblox, Salesforce, SunPower, TJX Companies, Upstart and Viatris.
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and Walgreens Boots Alliance.
Before U.S. markets open Monday morning, these four companies will be reporting quarterly earnings.
